Legacy Pharmaceuticals Switzerland GmbH in Liquidation
Company Overview
Previous Company Names
- Solco Pharmaceuticals Switzerland GmbH
- Legacy Pharmaceuticals Switzerland GmbH
Management
Legacy Pharmaceuticals International (Luxembourg) S.à.r.l.
Luxembourg, LU
Llc member
Michael Danzi
Las Vegas, US
Member of the executive board
Individual signing authority
Michael Danzi
Newport Beach / California, US
Llc member and member of the executive board
Individual signing authority
Danzi Capital Group
Newport Beach / California (US)
Llc member
Without signing authority
David John Smith
Zug
Member of the executive board
Individual signing authority
Legacy Pharmaceuticals International GmbH
Birsfelden
Llc member
Without signing authority
Leon Aillaud
Oberwil BL
Joint signing authority (any two to sign)
Doris Arab
Allschwil
Joint signing authority (any two to sign)
Hans-Jörg Brinkmann
Birsfelden
Joint signing authority (any two to sign)
Elisabeth Grossmann
Füllinsdorf
Joint signing authority (any two to sign)
Roland Häringer
Ziefen
Joint signing authority (any two to sign)
Klaus Killenberger
Therwil
Joint signing authority (any two to sign)
Vance White
Buus
Joint signing authority (any two to sign)
Martina Wössner
Lörrach
Joint signing authority (any two to sign)
David Tearle
Laguna Niguel
Member of the executive board
Joint signing authority (any two to sign)
Markus Thomas Allemann
Riehen
Joint signing authority (any two to sign)
Jeffrey Cole
Ladera Ranch / California
Joint signing authority (any two to sign)
Rainer Haynl
Rheinfelden (DE)
Joint signing authority (any two to sign)
Matthias Hoth
Basel
Joint signing authority (any two to sign)
George Kateyiannis
Coto de Caza / California
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 1484 | 11.03.2024 | 52 | 14.03.2024 | 1005985711 |
| 2 | 128 | 06.01.2021 | 6 | 11.01.2021 | 1005070298 |
| 3 | 6784 | 23.12.2020 | 253 | 29.12.2020 | 1005061252 |
| 4 | 6698 | 21.12.2020 | 251 | 24.12.2020 | 1005057856 |
| 5 | B6494 | 11.12.2020 | B245 | 16.12.2020 | 1005049209 |
| 6 | 6321 | 04.12.2020 | 240 | 09.12.2020 | 1005043208 |
| 7 | 2221 | 04.05.2020 | 88 | 07.05.2020 | 1004884595 |
| 8 | 2926 | 13.06.2019 | 115 | 18.06.2019 | 1004653703 |
| 9 | 2528 | 21.05.2019 | 100 | 24.05.2019 | 1004637836 |
| 10 | 4649 | 17.09.2018 | 182 | 20.09.2018 | 1004459458 |
Company Purpose
Herstellung von, Handel mit und Vertrieb von pharmazeutischen Produkten aller Art. Die Gesellschaft kann Finanzierungsgeschäfte (einschliesslich Kredit- und Darlehensgewährungen an Gesellschafter und verbundene Gesellschaften) tätigen und für Verpflichtungen ihrer Gesellschafter und von verbundenen Gesellschaften Sicherheiten insbesondere in Form von Garantien, Pfändern, Globalzessionen, Sicherungsübereignungen oder Sicherungsabtretungen stellen, mit oder ohne Gegenwert. Sie kann alle Transaktionen des Mobilien- und Immobilienverkehrs vornehmen sowie sich an anderen Unternehmen beteiligen.